Intrinsic Value of S&P & Nasdaq Contact Us

OmniAb, Inc. OABIW NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
38/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

OmniAb, Inc. (OABIW) has a negative trailing P/E of -2.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 2.5 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -33.91%, forward earnings yield 40.82%. PEG 0.01 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.01).
  • Forward P/E 2.5 — analysts expect a return to profitability with estimated EPS of $0.04 for FY2029.
  • PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -33.91% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 40.82% as earnings recover.

Overall SharesGrow Score: 36/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
38/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
0/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — OABIW

Valuation Multiples
P/E (TTM)-2.9
Forward P/E2.5
PEG Ratio0.01
Forward PEG0.01
P/B Ratio0.72
P/S Ratio9.12
EV/EBITDA-3.5
Per Share Data
EPS (TTM)$-0.51
Forward EPS (Est.)$0.04
Book Value / Share$2.09
Revenue / Share$0.15
FCF / Share$-0.29
Yields & Fair Value
Earnings Yield-33.91%
Forward Earnings Yield40.82%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 -82.5 0.00 5.14 61.18 -
2020 -63.8 -2.55 4.76 48.16 -
2021 -42.5 -0.71 4.90 33.04 -
2022 -13.8 -1.65 0.90 5.20 -
2023 -12.2 -0.13 1.96 18.00 -
2024 -5.8 -0.30 1.26 13.73 -
2025 -3.2 0.49 0.79 11.26 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-0.12 $18.32M $-13.59M -74.2%
2020 $-0.15 $23.27M $-17.56M -75.5%
2021 $-0.33 $34.75M $-27.04M -77.8%
2022 $-0.26 $59.08M $-22.33M -37.8%
2023 $-0.51 $34.16M $-50.62M -148.2%
2024 $-0.61 $26.39M $-62.03M -235.1%
2025 $-0.57 $18.67M $-64.78M -347%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.38 $-0.62 – $-0.26 $27.89M $25.46M – $30.25M 1
2027 $-0.26 $-0.42 – $-0.18 $45.94M $29.5M – $78.11M 1
2028 $-0.06 $-0.10 – $-0.04 $72.31M $53.83M – $106.12M 1
2029 $0.04 $0.02 – $0.06 $94.8M $70.57M – $139.13M 1
2030 $0.12 $0.08 – $0.19 $116.45M $86.69M – $170.91M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message